Group structure
8 companies in 2 countries
Loading your pageโฆ
Loading your pageโฆ
8 companies in 2 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 28
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACAM20001250000 pfu / 2.5 mcl ยท Powder For Solution | Vaccinia virus, live | Canada | Authorised | |
| Acam20001.0- 5.0 x 10^8 pfu/ml ยท Suspension | Smallpox vaccine, live | United States | Marketed | 2007 |
| ACAM20001.0 x10โธ - 5.0 x10โธ PFU/ml ยท Injection, powder, lyophilized, for solution | Live vaccina virus | Singapore | Authorised | 2009 |
| ACCRETROPIN5mg/ml (5mg/ml) ยท Injectable | Somatropin | United States | Not marketed | 2008 |
| ANTHRASIL60 unit / vial ยท Solution | Anthrax immunoglobulin | Canada | Authorised | |
| Anthrasil>=60 u ยท Injection | Anthrax immune globulin intravenous | United States | Marketed | 2015 |
| BAT4500 unit / vial + 3300 unit / vial + 3000 unit / vial + 600 unit / vial + 5100 unit / vial + 3000 unit / vial + 600 unit / vial ยท Solution | Botulinum antitoxin serotype a, Botulinum antitoxin serotype b, Botulinum antitoxin serotype c, Botulinum antitoxin serotype d, Botulinum antitoxin serotype, Botulinum antitoxin serotype f | Canada | Authorised | |
| Bat>4500u ยท Solution | Botulism antitoxin heptavalent | United States | Marketed | 2013 |
| BAT STERILE SOLUTION FOR INJECTION> 4500 U/vial + > 3300 U/vial + > 3000 U/vial + > 600 U/vial + > 5100 U/vial + > 3000 U/vial + > 600 U/vial ยท Injection, solution | Botulism antitoxin serotype a, Botulism antitoxin serotype b, Botulism antitoxin serotype c, Botulism antitoxin serotype d, Botulism antitoxin serotype, Botulism antitoxin serotype f | Singapore | Authorised | 2019 |
| Biorab1.0ml ยท Injection | Rabies vaccine adsorbed | United States | Not marketed | 1998 |
| Biothrax0.5ml ยท Injection | Anthrax vaccine adsorbed | United States | Marketed | 1998 |
| Biothrax0.5ml ยท Injection | Anthrax vaccine adsorbed | United States | Marketed | 1998 |
| BIOTHRAX50 mcg / 0.5 ml ยท Suspension | Anthrax antigen | Canada | Authorised | |
| BioThrax (Anthrax Vaccine Adsorbed) Supension for Injection 50ฮผg/dose (nominal)50ฮผg/dose (nominal) ยท Injection, suspension | Anthrax antigen | Singapore | Authorised | 2011 |
| Cnj-016>=50,000u ยท Injection | Vaccinia immune globulin intravenous | United States | Marketed | 2005 |
| CNJ-01650000 unit / vial ยท Solution | Vaccinia immunoglobulin | Canada | Authorised | |
| CYFENDUS100ug/ml ยท Injection | Anthrax vaccine adsorbed, adjuvanted | United States | Marketed | 2023 |
| NARCAN2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 4MG/SPRAY ยท Spray, metered | Naloxone | United States | Marketed | 2015 |
| NARCAN NASAL SPRAY2 mg / 0.1 ml ยท Spray (Metered-Dose) | Naloxone | Canada | Authorised | |
| NARCAN NASAL SPRAY4 mg / 0.1 ml ยท Spray (Metered-Dose) | Naloxone | Canada | Marketed | 2017 |
| TEMBEXA10 mg / ml ยท Suspension | Brincidofovir | Canada | Authorised | |
| TEMBEXA100 mg ยท Tablet | Brincidofovir | Canada | Authorised | |
| TEMBEXA10mg/ml ยท Suspension | Brincidofovir | United States | Marketed | 2021 |
| TEMBEXA100mg ยท Tablet | Brincidofovir | United States | Marketed | 2021 |
| HepaGam B | Hepatitis b immunoglobulin | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 12 | 12 | 0 | CompaniesAll medicines |
| Canada | 9 | 9 | 0 | CompaniesAll medicines |
| Saudi Arabia | 4 | 4 | 0 | CompaniesAll medicines |
| Singapore | 3 | 3 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.